Type 2 diabetes drug could be beneficial for head and neck cancer patients

Posted by on June 4, 2016 5:19 pm
Categories: health

Researchers have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.

Leave a Reply

Your email address will not be published. Required fields are marked *